Orthoproducts was an established provider (45% global market share) of high-quality, medical-grade ultra-high molecular weight polyethylene (UHMWPE) for hip, knee and spinal orthopaedic implants.

Harwood acquired the company through a divestment from a listed company and exited via a trade sale to a large medical device manufacturing and design company.

Fund Fund 2
Investment date April 2008
Deal type Buyout
Sector Health Services
Exit date October 2013
Exit type Trade sale
Back to Realised investments
City and trees